Generic placeholder image

Current Drug Delivery

Editor-in-Chief

ISSN (Print): 1567-2018
ISSN (Online): 1875-5704

Review Article

Artificial Intelligence in Pharmaceutical Field - A Critical Review

Author(s): Maithri H. Shanbhogue , Shailesh Thirumaleshwar*, Pramod Kumar Tegginamath and Hemanth Kumar Somareddy

Volume 18, Issue 10, 2021

Published on: 16 June, 2021

Page: [1456 - 1466] Pages: 11

DOI: 10.2174/1567201818666210617100613

Price: $65

Abstract

Artificial intelligence is an emerging sector in almost all fields. It is not confined only to a particular category and can be used in various fields like research, technology, and health. AI mainly concentrates on how computers analyze data and mimic the human thought process. As drug development involves high R & D costs and uncertainty in time consumption, artificial intelligence can serve as one of the promising solutions to overcome all these demerits. Due to the availability of enormous data, there are chances of missing out on some crucial details. To solve these issues, algorithms like machine learning, deep learning, and other expert systems are being used. On successful implementation of AI in the pharmaceutical field, the delays in drug development, failure at the clinical and marketing level can be reduced. This review comprises information regarding the development of AI, its subfields, its overall implementation, and its application in the pharmaceutical sector and provides insights on challenges and limitations concerning AI.

Keywords: Artificial intelligence, pharmaceutical sciences, drug development, data management, machine learning, computer-aided system.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy